South West Regional Experience of Alpelisib and Fulvestrant in Patients with a PIK3CA Mutation

被引：0
|
作者：
Crocker, C. [1 ]
Mckeon, J. [2 ]
Dacie, R. [3 ]
Amaya, M. [4 ]
机构：
[1] Royal United Hosp Bath NHS Fdn Trust, Bath, Avon, England
[2] Univ Hosp Bristol & Weston NHS Fdn Trust, Bristol, Avon, England
[3] Gloucestershire Hosp NHS Fdn Trust, Gloucester, England
[4] Somerset NHS Fdn Trust, Yeovil, England
来源：
CLINICAL ONCOLOGY | 2024年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E108 / E109
页数：2
相关论文
共 50 条
  • [21] PIK3CA mutation is predictive of poor survival in patients with colorectal cancer
    Kato, Shunsuke
    Iida, Satoru
    Higuchi, Tetsuro
    Ishikawa, Toshiaki
    Takagi, Yoko
    Yasuno, Masamichi
    Enomoto, Masayuki
    Uetake, Hiroyuki
    Sugihara, Kenichi
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (08) : 1771 - 1778
  • [22] Mutation of the PIK3CA gene in anaplastic thyroid cancer
    García-Rostán, G
    Costa, AM
    Pereira-Castro, I
    Salvatore, G
    Hernandez, R
    Hermsem, MJA
    Herrero, A
    Fusco, A
    Cameselle-Teijeiro, J
    Santoro, M
    CANCER RESEARCH, 2005, 65 (22) : 10199 - 10207
  • [23] New European approvals: Alpelisib for HRpos/HER2neg metastatic breast cancer with PIK3CA mutation
    Corbaux, Pauline
    Sabatier, Renaud
    BULLETIN DU CANCER, 2020, 107 (10) : 959 - 960
  • [24] Constitutional Mutation of PIK3CA: A Variant of Cowden Syndrome?
    Vida-Navas, Elena
    Barca-Tierno, Veronica
    Lopez-Gomez, Victoria
    Salazar, Maria Teresa
    Moreno-Pelayo, Miguel A.
    Guillen-Ponce, Carmen
    GENES, 2024, 15 (09)
  • [25] Phase Ib and pharmacokinetics study of alpelisib, a PIK3CA inhibitor, and capecitabine in patients with advanced solid tumors
    Lim, Ah Reum
    Kim, Boyeon
    Kim, Jwa Hoon
    Hyun, Myung Han
    Park, Kyong Hwa
    Kim, Yeul Hong
    Lee, Soohyeon
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [26] PIK3CA mutation and amplification in human lung cancer
    Okudela, Koji
    Suzuki, Masaya
    Kageyama, Shinji
    Bunai, Tomoyasu
    Nagura, Kiyoko
    Igarashi, Hisaki
    Takamochi, Kazuya
    Suzuki, Kazuya
    Yamada, Takeshi
    Niwa, Hiroshi
    Ohashi, Riuko
    Ogawa, Hiroshi
    Mori, Hiroki
    Kitamura, Hitoshi
    Kaneko, Takeshi
    Tsuneyoshi, Toshihiro
    Sugimura, Haruhiko
    PATHOLOGY INTERNATIONAL, 2007, 57 (10) : 664 - 671
  • [27] PIK3CA mutation enrichment and detection in clinical samples
    Keraite, Ieva
    Alvarez-Garcia, Virginia
    Del Favero, Jurgen
    Kersaudy-Kerhoas, Maiwenn
    Leslie, Nicholas
    CLINICAL CANCER RESEARCH, 2020, 26 (11) : 96 - 96
  • [28] PIK3CA mutation and colorectal cancer precision medicine
    Hamada, Tsuyoshi
    Nowak, Jonathan A.
    Ogino, Shuji
    ONCOTARGET, 2017, 8 (14) : 22305 - 22306
  • [29] Liquid biopsy for PIK3Ca mutation in cervical cancer
    Chung, T. K. H.
    Cheung, T. H.
    Yim, S. F.
    Wong, R. R. Y.
    Elias, K.
    Smith, D.
    Berkowitz, R. S.
    Wong, Y. F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 489 - 489
  • [30] Mutation of the PIK3CA gene in ovarian and breast cancer
    Campbell, IG
    Russell, SE
    Choong, DYH
    Montgomery, KG
    Ciavarella, ML
    Hooi, CSF
    Cristiano, BE
    Pearson, RB
    Phillips, WA
    CANCER RESEARCH, 2004, 64 (21) : 7678 - 7681
12345